Schrodinger is engaged in developing a physics-based software platform that enables discovery of molecules for drug development and materials applications. Co.'s software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Co. has two segments: software, which is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries; and drug discovery, which is focused on various portfolio of preclinical and clinical programs, internally and through collaborations, that have developed to various stages of discovery and development. The SDGR stock yearly return is shown above.
The yearly return on the SDGR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SDGR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|